COMMUNIQUÉS West-GlobeNewswire

-
Imidex and Spesana Form Strategic Partnership to Impact Early Lung Cancer Detection and Patient Outcomes
11/07/2024 -
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform
11/07/2024 -
CervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024
11/07/2024 -
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
11/07/2024 -
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
11/07/2024 -
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
11/07/2024 -
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
10/07/2024 -
MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation
10/07/2024 -
Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025
10/07/2024 -
Desert Hope Treatment Center Promotes Kristin Berg to Executive Director, Solidifying its Position as a Market Leader
10/07/2024 -
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
10/07/2024 -
GrayHawk Health Leverages Innovaccer’s Technology to Transform In-Home Healthcare for At Risk Populations
10/07/2024 -
Elite MedSpa, Ivy En Rose, Unveils Groundbreaking Longevity Program and Announces Upcoming Launch of Membership Rewards
10/07/2024 -
FSH-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomized clinical trial
10/07/2024 -
Shineco Announces New Distribution Agreements for over $30 Million in Sales for its New Health Food Beverage
10/07/2024 -
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10/07/2024 -
Two USOSM Partner Practices Receive AAAHC Accreditation
10/07/2024 -
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
10/07/2024 -
Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction
10/07/2024
Pages